Saturday 17 October 2026
Export INBX’s income statement to Excel — free account
Inhibrx Biosciences, Inc.
INBX Healthcare Biotechnology
Inhibrx Biosciences, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $1.3 million, up 550.0% from fiscal 2024. In the quarter to June 2026, revenue grew 992.4%, EPS fell 26.5%, free cash flow was flat and total debt rose 77.6%, each against the same quarter a year earlier. Insiders bought in the last twelve months.
89.83
0.67
−0.74%
Follow INBX
| Jun '26 | Mar '26 | Dec '25 | Sep '25 | Older periods | |
|---|---|---|---|---|---|
| (1,773.60%) | (354.69%) | (197.85%) | (144.07%) |
+8 more TTM periods Free account |
|
| (75.44%) | (61.03%) | (85.60%) | (77.54%) | ||
ROIC |
0.00% | 0.00% | 0.00% | 0.00% | |
Return on Tangible Assets |
(118.27%) | (87.95%) | (136.29%) | (119.53%) | |
Average Days of Receivables |
0.00 | 0.00 | 0.00 | 0.00 | |
Free Cash Flow per Share |
(8.42) | (8.46) | (8.38) | (9.27) | |
Free Cash Flow |
(131.89) | (131.92) | (129.82) | (143.44) | |
Capital Expenditures |
— | — | (0.03) | (0.04) | |
| Other line items | |||||
Cash ROIC |
(51.39%) | (41.80%) | (55.77%) | (49.49%) | |
Accounts Receivable Turnover |
0.00 | 0.00 | 0.00 | 0.00 | |
Accounts Payable Turnover |
0.00 | 0.00 | 0.00 | 0.00 | |
Average Days of Payables |
0.00 | 0.00 | 0.00 | 0.00 | |
Tax Rate |
0.00 | 0.00 | 0.00 | 0.00 | |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Selling, General and Administrative Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Share Based Compensation of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Interest Coverage |
(8.21) | (9.45) | (11.07) | (8.99) | |
Operating CF/Net income |
0.95 | 1.01 | 0.93 | 0.92 | |
Depreciation/Fixed assets |
0.82 | 0.73 | 0.67 | 0.61 | |
Capex/Depreciation |
0.00 | 0.00 | (0.01) | (0.02) | |
Revenue per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Operating CF per Share |
(8.42) | (8.46) | (8.38) | (9.26) | |
Capex per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Capex to Sales |
— | — | 0.00 | 0.00 |
Columns are period end dates